BioSpace News Archive

OncoSec Medical Incorporated (“OncoSec”) (Nasdaq:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced outcomes from a safety and biomarker analysis on its lead product candidate, TAVO™, at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting.

Martin will apply his extensive knowledge and experience to guide internal and external clients throughout their bioanalysis and immunomodulation analysis projects.

Live Webcast of Data Presentation and Discussion by KOL, Tarek I. Hassanein, M.D. at Noon ET on Tuesday, November 12, 2019

Continues focus on transformative solutions while spin-off brings award-winning learning programs to national audience

Four presentations will highlight data from one of the largest industry-sponsored registries of aortic stent grafts

Dr. David Shafer of Shafer Plastic Surgery and Laser Center in midtown Manhattan, announces the acquisition of the Vbeam® Prima™ Laser System by Candela, an advanced 595 nm pulsed dye laser (PDL).

Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) today announces that it has scheduled a conference call and webcast to supplement the presentation of BETonMACE results to be made during the American Heart Association’s (“AHA”) annual conference.

NewLink Genetics Corporation (NASDAQ:NLNK) announced that Monday, November 11th, the European Commission (EC) granted a conditional marketing authorization to ERVEBO®, investigational V920 Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP), as confirmed by our partner, Merck (NYSE:MRK), known as MSD outside the US and Canada.

Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today reported recent business highlights and financial results for the third quarter ended September 30, 2019.

BioNovelus, Inc. (OTC: ONOV) announces it has submitted its 2019 3Q report on www.otcmarkets.com.